GASTROESOPHAGEAL CANCER

This study is testing if a two-part strategy works better for advanced stomach cancer that has spread a little. One group gets strong drug therapy (immunotherapy plus chemo) followed by surgery to remove all visible tumors. The other group gets the drug therapy alone. The goal is…

This is an early-stage study testing a new oral drug called BG-68501 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see how the body processes the drug, both when given alone and when combined with…

This study is testing a new combination of four drugs for people with advanced stomach or esophageal cancer that has a specific genetic feature called HER2. The goal is to see if adding the drug neratinib to standard chemotherapy and two other targeted drugs is safe and can bette…

This study is testing an experimental drug called zanidatamab for people with advanced cancers that have a specific marker called HER2 and have stopped responding to prior treatments. It will enroll about 200 adults with various cancers including breast, lung, stomach, and ovaria…

This study compares two types of minimally invasive stomach cancer surgeries to see which one helps patients maintain their appetite and weight better after treatment. Researchers are looking at 20 patients with early-stage stomach or gastroesophageal cancer who need surgery with…

This study is testing whether a remote support program can help people with stomach or esophageal cancer avoid malnutrition during treatment. Participants will use a phone app to track food and meet with a dietitian remotely, comparing this approach to usual care. The goal is to …

This study aims to collect blood and tissue samples from people with various cancers to help develop better blood tests. Researchers want to see if these tests can detect tiny amounts of leftover cancer cells after treatment, which might help predict if the cancer could return. P…